Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Evercore ISI Group Maintains Outperform on Noble Corp, Raises Price Target to $53

Evercore ISI Group analyst James West maintains Noble Corp (NYSE:NE) with a Outperform and raises the price target from $49 to $53.
byBenzinga Newsdesk
February 28, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Evercore ISI Group analyst James West maintains Noble Corp (NYSE:NE) with a Outperform and raises the price target from $49 to $53.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Junshi Biosciences and Coherus Announced FDA Has Been Unable to Travel to China to Conduct the Required Site Inspection Resulting in Delayed Action on the BLA for Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma

By Charles Gross
December 25, 9:20 AM
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. ("Coherus", Nasdaq: CHRS) today announced that the companies have not received an action letter from the U.S.

CHRS